Related Experiment Video

Updated: Apr 16, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.8K

Targeting PTEN using small molecule inhibitors

Lok Hang Mak1, Rudiger Woscholski2

  • 1Department of Chemistry, Imperial College London, Exhibition Road, London SW7 2AZ, UK.

Methods (San Diego, Calif.)
|March 10, 2015
PubMed

Insights

This review explores small molecules that inhibit PTEN (phosphatase and tensin homologue deleted on chromosome 10), a key tumor suppressor. PTEN inhibition is a promising therapeutic strategy for diabetes, stroke, and other conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • PTEN (phosphatase and tensin homologue deleted on chromosome 10) functions as a tumor suppressor.
  • PTEN counteracts phosphoinositide 3-kinase (PI3K) signaling through its lipid phosphatase activity.
  • PTEN regulates Akt kinase, impacting insulin signaling, glucose uptake, and cell growth.

Purpose of the Study:

  • To review the development and application of small molecules as PTEN inhibitors.
  • To discuss current methodologies for assessing PTEN inhibition in vitro and in cellulo.

Main Methods:

  • Literature review of small molecule PTEN inhibitors.
  • Discussion of in vitro and in cellulo assays for PTEN inhibition.

Main Results:

  • Small molecules are being developed to target PTEN.
  • Various methods exist to evaluate PTEN inhibition efficacy.

Conclusions:

  • PTEN is a significant drug target for metabolic and cardiovascular diseases.
  • Small molecule inhibitors offer a potential therapeutic avenue for conditions involving PTEN dysregulation.
Keywords:
InhibitionOMFPPTENVO-OHpicVanadium compounds

More Related Videos

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

6.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K